NDC Package 13533-661-06 Hyperrho S/d Mini-dose

Rho(d) Immune Globulin (human) Solution Intramuscular - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
13533-661-06
Package Description:
10 SYRINGE in 1 CARTON / 1 SOLUTION in 1 SYRINGE (13533-661-60)
Product Code:
Proprietary Name:
Hyperrho S/d Mini-dose
Non-Proprietary Name:
Rho(d) Immune Globulin (human)
Substance Name:
Human Rho(d) Immune Globulin
Usage Information:
HyperRHO S/D Mini-Dose is recommended to prevent the isoimmunization of Rho(D) negative women at the time of spontaneous or induced abortion of up to 12 weeks’ gestation provided the following criteria are met:The mother must be Rho(D) negative and must not already be sensitized to the Rho(D) antigen. The father is not known to be Rho(D) negative.Gestation is not more than 12 weeks at termination.Note: Rho(D) Immune Globulin (Human) prophylaxis is not indicated if the fetus or father can be determined to be Rh negative. If the Rh status of the fetus is unknown, the fetus must be assumed to be Rho(D) positive, and HyperRHO S/D Mini-Dose should be administered to the mother.FOR ABORTIONS OR MISCARRIAGES OCCURRING AFTER 12 WEEKS’ GESTATION, A STANDARD DOSE OF Rho(D) IMMUNE GLOBULIN (HUMAN) IS INDICATED.HyperRHO S/D Mini-Dose should be administered within 3 hours or as soon as possible after spontaneous passage or surgical removal of the products of conception. However, if HyperRHO S/D Mini-Dose is not given within this time period, consideration should still be given to its administration since clinical studies in male volunteers have demonstrated the effectiveness of Rho(D) Immune Globulin (Human) in preventing isoimmunization as long as 72 hours after infusion of Rho(D) positive red cells. [9]
11-Digit NDC Billing Format:
13533066106
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
10 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1790353 - rho(D) immune globulin, human 250 UNT (50 MCG) Prefilled Syringe
  • RxCUI: 1790353 - Rho(D) immune globulin, human 250 UNT Prefilled Syringe
  • RxCUI: 898572 - HyperRHO Mini-Dose 250 UNT (50 MCG) Prefilled Syringe
  • RxCUI: 898572 - Rho(D) immune globulin, human 250 UNT Prefilled Syringe [HyperRHO]
  • RxCUI: 898572 - HyperRHO 250 UNT Prefilled Syringe
  • Product Type:
    Plasma Derivative
    Labeler Name:
    Grifols Usa, Llc
    Dosage Form:
    Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
  • Sample Package:
    No
    FDA Application Number:
    BLA101141
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    08-14-1996
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 13533-661-06 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    13533066106J2788Rho d immune globulin 50 mcg50 MCG110110

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 13533-661-06?

    The NDC Packaged Code 13533-661-06 is assigned to a package of 10 syringe in 1 carton / 1 solution in 1 syringe (13533-661-60) of Hyperrho S/d Mini-dose, a plasma derivative labeled by Grifols Usa, Llc. The product's dosage form is solution and is administered via intramuscular form.This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package.

    Is NDC 13533-661 included in the NDC Directory?

    Yes, Hyperrho S/d Mini-dose with product code 13533-661 is active and included in the NDC Directory. The product was first marketed by Grifols Usa, Llc on August 14, 1996 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 13533-661-06?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 10.

    What is the 11-digit format for NDC 13533-661-06?

    The 11-digit format is 13533066106. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-213533-661-065-4-213533-0661-06